A subset of patients with stage III colon cancer when treated with irinotecan-based therapy had improved survival rates. This is according to a new study in emGastroenterology/emsup1/sup, the official journal of the American Gastroenterological Association. When added to the standard chemotherapy treatment - fluorouracil and leucovorin - adjuvant irinotecan therapy improved overall survival rates for patients with the CpG island methylator phenotype ...Sunday, 31 August 2014
Drug Shows Promise for Subset of Patients With Stage III Colon Cancer
A subset of patients with stage III colon cancer when treated with irinotecan-based therapy had improved survival rates. This is according to a new study in emGastroenterology/emsup1/sup, the official journal of the American Gastroenterological Association. When added to the standard chemotherapy treatment - fluorouracil and leucovorin - adjuvant irinotecan therapy improved overall survival rates for patients with the CpG island methylator phenotype ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment